Orthopedics, Department of Clinical and Experimental Medicine, Linköping University, SE-58185, Linköping, Sweden.
Bone. 2013 Apr;53(2):515-9. doi: 10.1016/j.bone.2013.01.018. Epub 2013 Jan 19.
The Sost gene encodes Sclerostin, an inhibitor of Wnt-signaling, generally considered a main response gene to mechanical loading in bone. Several papers describe that unloading leads to upregulation of Sost, which in turn may lead to loss of bone. These studies were based on whole bone homogenates or cortical bone. By serendipity, we noted an opposite response to unloading in the proximal rat tibia. Therefore, we hypothesized that Sost-expression in response to changes in mechanical load is bone site specific. One hind limb of male, 3 month old rats was unloaded by paralyzing the extensors with Botulinium toxin A (Botox) injections. A series of experiments compared the expression of Sost mRNA in the unloaded and contralateral, loaded limbs, after 3 or 10 days, in metaphyseal cancellous bone, metaphyseal cortical bone, and diaphyseal cortical bone. We also conducted μCT to confirm changes in bone volume density related to unloading. Sost mRNA expression in the cancellous metaphyseal bone was downregulated almost 2-fold, both 3 days and 10 days after unloading (P<0.05). A similar tendency was seen in the metaphyseal cortical bone, in which Sost was 1.5-fold downregulated (P<0.05) after 10days, but not significantly changed after 3days. In contrast, diaphyseal cortical Sost expression was instead upregulated 1.4-fold (P<0.05) following 3-day unloading, while there was no significant change after 10days. Cancellous bone volume density was 58% lower (P<0.001, compared to cage controls) in the unloaded limb but not significantly affected in the loaded limb. The results suggest that Sost mRNA expression in metaphyseal bone responds to mechanical unloading in an opposite direction to that observed in diaphyseal cortical bone. This proposes a more complex expression pattern for Sost in response to unloading. Therapeutics that target Sclerostin during altered loading conditions may result in local bone mass changes that are difficult to predict.
Sost 基因编码骨硬化蛋白(Sclerostin),它是 Wnt 信号通路的抑制剂,通常被认为是骨骼对机械负荷的主要反应基因。有几篇论文描述了去负荷会导致 Sost 的上调,而这反过来又可能导致骨丢失。这些研究是基于整个骨匀浆或皮质骨进行的。我们偶然注意到,在大鼠近侧胫骨中,去负荷会导致相反的反应。因此,我们假设 Sost 表达对机械负荷变化的反应是骨部位特异性的。雄性 3 月龄大鼠的一条后肢通过注射肉毒杆菌毒素 A(Botox)麻痹伸肌来进行去负荷。一系列实验比较了 3 天和 10 天后,未负荷侧和负荷侧的近侧松质骨、近侧皮质骨和远侧皮质骨中 Sost mRNA 的表达情况,同时还进行了 μCT 以确认与去负荷相关的骨体积密度的变化。去负荷 3 天和 10 天后,松质骨近侧 Sost mRNA 的表达几乎下调了 2 倍(P<0.05)。在近侧皮质骨中也出现了类似的趋势,Sost 在 10 天后下调了 1.5 倍(P<0.05),但在 3 天后没有明显变化。相比之下,远侧皮质骨中的 Sost 表达反而上调了 1.4 倍(P<0.05),而在 10 天后没有明显变化。未负荷侧的松质骨体积密度降低了 58%(P<0.001,与笼中对照组相比),但负荷侧没有明显影响。结果表明,近侧骨中 Sost mRNA 的表达对机械去负荷的反应与远侧皮质骨中观察到的反应相反。这提出了 Sost 对去负荷的反应的更复杂的表达模式。在改变的加载条件下靶向 Sclerostin 的治疗可能会导致局部骨量变化,这很难预测。